Arkema (OTCMKTS:ARKAY - Get Free Report) is expected to issue its quarterly earnings data on Tuesday, May 6th. Analysts expect the company to announce earnings of $1.45 per share and revenue of $2.44 billion for the quarter.
Arkema Price Performance
Shares of ARKAY traded up $0.39 during midday trading on Friday, hitting $75.79. 4,013 shares of the company traded hands, compared to its average volume of 16,483. The stock has a market cap of $5.76 billion, a price-to-earnings ratio of 15.16, a PEG ratio of 0.53 and a beta of 1.11. The firm has a 50 day moving average of $78.06 and a 200-day moving average of $79.84. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.54 and a current ratio of 2.11. Arkema has a 52 week low of $64.94 and a 52 week high of $111.13.
Wall Street Analyst Weigh In
Separately, Sanford C. Bernstein initiated coverage on Arkema in a report on Thursday, April 24th. They set an "underperform" rating for the company.
View Our Latest Stock Analysis on Arkema
About Arkema
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Featured Articles

Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.